DEA schedule
Is octreotide acetate a controlled substance?
Federal schedule for octreotide acetate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Octreotide acetate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and octreotide acetate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted octreotide acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 33 prescription listings from 10 labelers, none with a DEA schedule |
| DEA controlled substances list | octreotide acetate is not on the list |
Octreotide Acetate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 62756-452 | BYNFEZIA Pen | injection | 2.5 mg/mL | Sun Pharmaceutical Industries, Inc. | None |
| 0078-0181 | Sandostatin | injection, solution | 100 ug/mL | Novartis Pharmaceuticals Corporation | None |
| 0078-0180 | Sandostatin | injection, solution | 50 ug/mL | Novartis Pharmaceuticals Corporation | None |
| 0078-0182 | Sandostatin | injection, solution | 500 ug/mL | Novartis Pharmaceuticals Corporation | None |
| 63323-376 | Octreotide | injection, solution | 100 ug/mL | Fresenius Kabi USA, LLC | None |
| 63323-376 | Octreotide | injection, solution | 100 ug/mL | Fresenius Kabi USA, LLC | None |
| 63323-379 | Octreotide | injection, solution | 1000 ug/mL | Fresenius Kabi USA, LLC | None |
| 63323-378 | Octreotide | injection, solution | 200 ug/mL | Fresenius Kabi USA, LLC | None |
| 63323-377 | Octreotide | injection, solution | 500 ug/mL | Fresenius Kabi USA, LLC | None |
| 63323-377 | Octreotide | injection, solution | 500 ug/mL | Fresenius Kabi USA, LLC | None |
| 0641-6175 | Octreotide Acetate | injection, solution | 100 ug/mL | Hikma Pharmaceuticals USA Inc. | None |
| 23155-688 | OCTREOTIDE ACETATE | injection, solution | 100 ug/mL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 52958-046 | OCTREOTIDE ACETATE | injection, solution | 100 ug/mL | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | None |
| 67457-245 | Octreotide Acetate | injection, solution | 100 ug/mL | Mylan Institutional LLC | None |
| 68083-517 | Octreotide Acetate | injection, solution | 100 ug/mL | Gland Pharma Limited | None |
| 68462-896 | Octreotide Acetate | injection, solution | 100 ug/mL | GLENMARK PHARMACEUTICALS INC., USA | None |
| 71288-567 | Octreotide Acetate | injection, solution | 100 ug/mL | Meitheal Pharmaceuticals, Inc. | None |
| 0641-6178 | Octreotide Acetate | injection, solution | 1000 ug/mL | Hikma Pharmaceuticals USA Inc. | None |
| 23155-686 | OCTREOTIDE ACETATE | injection, solution | 1000 ug/mL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 68083-516 | Octreotide Acetate | injection, solution | 1000 ug/mL | Gland Pharma Limited | None |
| 0641-6177 | Octreotide Acetate | injection, solution | 200 ug/mL | Hikma Pharmaceuticals USA Inc. | None |
| 23155-685 | OCTREOTIDE ACETATE | injection, solution | 200 ug/mL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 68083-515 | Octreotide Acetate | injection, solution | 200 ug/mL | Gland Pharma Limited | None |
| 0641-6174 | Octreotide Acetate | injection, solution | 50 ug/mL | Hikma Pharmaceuticals USA Inc. | None |
| 23155-687 | OCTREOTIDE ACETATE | injection, solution | 50 ug/mL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 67457-239 | Octreotide Acetate | injection, solution | 50 ug/mL | Mylan Institutional LLC | None |
| 71288-566 | Octreotide Acetate | injection, solution | 50 ug/mL | Meitheal Pharmaceuticals, Inc. | None |
| 0641-6176 | Octreotide Acetate | injection, solution | 500 ug/mL | Hikma Pharmaceuticals USA Inc. | None |
| 23155-689 | OCTREOTIDE ACETATE | injection, solution | 500 ug/mL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 67457-246 | Octreotide Acetate | injection, solution | 500 ug/mL | Mylan Institutional LLC | None |
| 68083-560 | Octreotide Acetate | injection, solution | 500 ug/mL | Gland Pharma Limited | None |
| 68462-897 | Octreotide Acetate | injection, solution | 500 ug/mL | GLENMARK PHARMACEUTICALS INC., USA | None |
| 71288-568 | Octreotide Acetate | injection, solution | 500 ug/mL | Meitheal Pharmaceuticals, Inc. | None |
Questions
Is octreotide acetate a controlled substance?
No. Octreotide acetate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and octreotide acetate is not on the DEA controlled substances list.
Is octreotide acetate a narcotic?
No. Octreotide acetate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Somatostatin Analog.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Octreotide Acetate
- What is Octreotide Acetate used for?FDA label uses
- Generic for MycapssaFDA Orange Book
- Generic for SandostatinFDA Orange Book
- Generic for Sandostatin LarFDA Orange Book
- Generic for BYNFEZIA PenFDA Orange Book
- Somatostatin Analogs listFDA drug class
- NDC 0078-0180Octreotide Acetate NDC record
- NDC 0078-0181Octreotide Acetate NDC record
- NDC 0078-0182Octreotide Acetate NDC record